Unknown

Dataset Information

0

Interferon ? and Anti-PD-1/PD-L1 Checkpoint Blockade Cooperate in NK Cell-Mediated Killing of Nasopharyngeal Carcinoma Cells.


ABSTRACT: Nasopharyngeal carcinoma (NPC) is a highly malignant epithelial cancer linked to EBV infection. Addition of interferon-? (IFN?) to chemo- and radiochemotherapy has led to survival rates >90% in children and adolescents. As NPC cells are sensitive to apoptosis via tumor necrosis factor-related apoptosis inducing ligand (TRAIL), we explored the role of TRAIL and IFN? in the killing of NPC cells by natural killer (NK) cells. NPC cells, including cells of a patient-derived xenograft were exposed to NK cells in the presence or absence of IFN?. NK cells killed NPC- but not nasoepithelial cells and killing was predominately mediated via TRAIL. Incubation of NK cells with IFN? increased cytotoxicity against NPC cells. Concomitant incubation of NK- and NPC cells with IFN? before coculture reduced cytotoxicity and could be overcome by blocking the PD-1/PD-L1 axis leading to the release of intracellular TRAIL from NK cells. In conclusion, combination of IFN? and anti-PD-1, augmenting cytotoxicity of NK cells against NPC cells, could be a strategy to improve NPC-directed therapy and warrants further evaluation in vivo.

SUBMITTER: Makowska A 

PROVIDER: S-EPMC6617170 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Interferon β and Anti-PD-1/PD-L1 Checkpoint Blockade Cooperate in NK Cell-Mediated Killing of Nasopharyngeal Carcinoma Cells.

Makowska Anna A   Braunschweig Till T   Denecke Bernd B   Shen Lian L   Baloche Valentin V   Busson Pierre P   Kontny Udo U  

Translational oncology 20190708 9


Nasopharyngeal carcinoma (NPC) is a highly malignant epithelial cancer linked to EBV infection. Addition of interferon-β (IFNβ) to chemo- and radiochemotherapy has led to survival rates >90% in children and adolescents. As NPC cells are sensitive to apoptosis via tumor necrosis factor-related apoptosis inducing ligand (TRAIL), we explored the role of TRAIL and IFNβ in the killing of NPC cells by natural killer (NK) cells. NPC cells, including cells of a patient-derived xenograft were exposed to  ...[more]

Similar Datasets

| S-EPMC6209395 | biostudies-literature
| S-EPMC6205063 | biostudies-literature
| S-EPMC4497957 | biostudies-literature
| S-EPMC5290437 | biostudies-literature
| S-EPMC6159991 | biostudies-literature
| S-EPMC6380009 | biostudies-literature
| S-EPMC6136863 | biostudies-other
| S-EPMC5360064 | biostudies-literature
| S-EPMC5906604 | biostudies-literature